5-Bromo-4-chloro-2-methyl-7H-pyrrolo[2,3-d]pyrimidine

Catalog No.: 
ACEIWZ158
CAS No.: 
1111237-76-3
Molecular Formula: 
C7H5BrClN3
Molecular Weight: 
246.49
5-Bromo-4-chloro-2-methyl-7H-pyrrolo[2,3-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$60.00In stockInquiry
5g95%$294.00InquiryInquiry
25g95%$1455.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-4-chloro-2-methyl-7H-pyrrolo[2,3-d]pyrimidine
IUPAC Name5-bromo-4-chloro-2-methyl-7H-pyrrolo[2,3-d]pyrimidine
MDL No.MFCD16249868
Molecular FormulaC7H5BrClN3
Molecular Weight246.49
SMILESCC1=NC2=C(C(Br)=CN2)C(Cl)=N1
InChI KeyXGBXHIJPFPEGBV-UHFFFAOYSA-N
Synonym5-Bromo-4-chloro-2-methyl-7H-pyrrolo[2,3-d]pyrimidine | 1111237-76-3 | MFCD16249868 | SCHEMBL13215442 | DTXSID60732032 | AMY14075 | AKOS016002455 | SB16457 | DS-15792 | SY099583 | CS-0050591 | EN300-360079 | O11375 | A856000
CAS No.1111237-76-3
PubChem CID59442280

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACEIWZ158 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEIWZ158 route product structure diagram
    ACEIWZ1581111237-76-3In Stock
Inquiry

2. ACEIWZ158 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEIWZ158 route product structure diagram
    ACEIWZ1581111237-76-3In Stock
Inquiry

3. ACEIWZ158 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEIWZ158 route product structure diagram
    ACEIWZ1581111237-76-3In Stock
Inquiry

Comments (0)